118 related articles for article (PubMed ID: 27838251)
1. Complex formation equilibria of Cu
Lachowicz JI; Nurchi VM; Crisponi G; Jaraquemada-Pelaez MG; Caltagirone C; Peana M; Zoroddu MA; Szewczuk Z; Cooper GJ
Eur J Pharm Sci; 2017 Jan; 97():158-169. PubMed ID: 27838251
[TBL] [Abstract][Full Text] [Related]
2. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites.
Nurchi VM; Crisponi G; Crespo-Alonso M; Lachowicz JI; Szewczuk Z; Cooper GJ
Dalton Trans; 2013 May; 42(17):6161-70. PubMed ID: 23202417
[TBL] [Abstract][Full Text] [Related]
3. Candesartan, losartan and valsartan Zn(II) complexes interactions with bovine serum albumin.
Martínez VR; Ferrer EG; Williams PA
Future Med Chem; 2022 Jan; 14(1):9-16. PubMed ID: 34730021
[No Abstract] [Full Text] [Related]
4. Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)-irbesartan complex: structure-antihypertensive activity relationships in Cu(II)-sartan complexes.
Islas MS; Luengo A; Franca CA; Merino MG; Calleros L; Rodriguez-Puyol M; Lezama L; Ferrer EG; Williams PA
J Biol Inorg Chem; 2016 Oct; 21(7):851-63. PubMed ID: 27507083
[TBL] [Abstract][Full Text] [Related]
5. Complex formation equilibria of polyamine ligands with copper(II) and zinc(II).
Nurchi VM; Crisponi G; Sanna G; Pérez-Toro I; Niclos-Gutierrez J; Gonzalez-Perez MJ; Domínguez Martín A
J Inorg Biochem; 2019 May; 194():26-33. PubMed ID: 30807891
[TBL] [Abstract][Full Text] [Related]
6. Mononuclear [(BP)(2)MX](n+) (M = Cu(2+), Co(2+), Zn(2+); X = OH(2), Cl(-)) complexes with a new biphenyl appended N-bidentate ligand: structural, spectroscopic, solution equilibrium and ligand dynamic studies.
Sabiah S; Varghese B; Murthy NN
Dalton Trans; 2009 Nov; (44):9770-80. PubMed ID: 19885522
[TBL] [Abstract][Full Text] [Related]
7. A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.
Fujino M; Miura S; Kiya Y; Tominaga Y; Matsuo Y; Karnik SS; Saku K
Hypertens Res; 2010 Oct; 33(10):1044-52. PubMed ID: 20668453
[TBL] [Abstract][Full Text] [Related]
8. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.
Peana M; Medici S; Nurchi VM; Lachowicz JI; Crisponi G; Garribba E; Sanna D; Zoroddu MA
J Inorg Biochem; 2017 Jun; 171():18-28. PubMed ID: 28343065
[TBL] [Abstract][Full Text] [Related]
9. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity.
Nurchi VM; Crisponi G; Arca M; Crespo-Alonso M; Lachowicz JI; Mansoori D; Toso L; Pichiri G; Amelia Santos M; Marques SM; Niclós-Gutiérrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z; Antonietta Zoroddu M; Peana M
J Inorg Biochem; 2014 Dec; 141():132-143. PubMed ID: 25260149
[TBL] [Abstract][Full Text] [Related]
10. Efforts to understand the molecular basis of hypertension through drug:membrane interactions.
Mavromoustakos T; Zoumpoulakis P; Kyrikou I; Zoga A; Siapi E; Zervou M; Daliani I; Dimitriou D; Pitsas A; Kamoutsis C; Laggner P
Curr Top Med Chem; 2004; 4(4):445-59. PubMed ID: 14965311
[TBL] [Abstract][Full Text] [Related]
11. Protolytic Equilibria of Sartans in Micellar Solutions of Differently Charged Surfactants.
Grujić M; Popović M; Popović G; Nikolic K; Agbaba D
J Pharm Sci; 2016 Aug; 105(8):2444-52. PubMed ID: 27422089
[TBL] [Abstract][Full Text] [Related]
12. Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartan.
Bramlage P; Schindler C
Expert Opin Pharmacother; 2010 Mar; 11(4):521-35. PubMed ID: 20030566
[TBL] [Abstract][Full Text] [Related]
13. Control of size in losartan/copper(II) coordination complex hydrophobic precipitate.
Denadai ÂM; Da Silva JG; Guimarães PP; Gomes LB; Mangrich AS; de Rezende EI; Daniel IM; Beraldo H; Sinisterra RD
Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):3916-22. PubMed ID: 23910296
[TBL] [Abstract][Full Text] [Related]
14. 2-tert-Butyl-5-(2-pyridyl)-2H-tetrazole as a chelating ligand in the direct synthesis of novel Cu(II) and heterobimetallic Cu(II)/Mn(II) complexes.
Mosalkova AP; Voitekhovich SV; Lyakhov AS; Ivashkevich LS; Lach J; Kersting B; Gaponik PN; Ivashkevich OA
Dalton Trans; 2013 Feb; 42(8):2985-97. PubMed ID: 23258667
[TBL] [Abstract][Full Text] [Related]
15. Losartan: Comprehensive Profile.
Al-Majed AR; Assiri E; Khalil NY; Abdel-Aziz HA
Profiles Drug Subst Excip Relat Methodol; 2015; 40():159-94. PubMed ID: 26051686
[TBL] [Abstract][Full Text] [Related]
16. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe
Nurchi VM; Crisponi G; Lachowicz JI; Jaraquemada-Pelaez MG; Bretti C; Peana M; Medici S; Zoroddu MA
J Inorg Biochem; 2018 Dec; 189():103-114. PubMed ID: 30243118
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Zn with Losartan. Activation of Intrinsic Apoptotic Signaling Pathway in Lung Cancer Cells and Effects on Alkaline and Acid Phosphatases.
Martínez VR; Aguirre MV; Todaro JS; Piro OE; Echeverría GA; Naso LG; Ferrer EG; Williams PAM
Biol Trace Elem Res; 2018 Dec; 186(2):413-429. PubMed ID: 29651733
[TBL] [Abstract][Full Text] [Related]
18. Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies.
Lachowicz JI; Crespo-Alonso M; Caltagirone C; Alberti G; Biesuz R; Orton JO; Nurchi VM
J Trace Elem Med Biol; 2018 Dec; 50():580-588. PubMed ID: 29685783
[TBL] [Abstract][Full Text] [Related]
19. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
[TBL] [Abstract][Full Text] [Related]
20. Structure elucidation and conformational study of V8: a novel synthetic non peptide AT(1) antagonist.
Zoumpoulakis P; Politi A; Grdadolnik SG; Matsoukas J; Mavromoustakos T
J Pharm Biomed Anal; 2006 Mar; 40(5):1097-104. PubMed ID: 16260110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
